Canadian application, no grantCanada
Stable pharmaceutical composition comprising erythropoietin
CA 2492485 A1 · Owner: Svetek, Jelka · Inventors: Paris, Alenka; Vukmirovic, Andreja; Rozman Peterka, Tanja
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a new stable pharmaceutical composition of erythropoietin (EPO) that is stabilized with a combination of a poloxamer polyol and a polyhydric alcohol.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 14, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 14, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 14, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 14, 2003
GrantedNo grant recorded
Term endedJuly 14, 2023
Patent numberCA 2492485 A1
Classification (IPC)A61K38/18 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.